Mannatech (NASDAQ:MTEX – Get Free Report) issued its quarterly earnings results on Thursday. The company reported $4.61 earnings per share (EPS) for the quarter, FiscalAI reports. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 6.90%. The business had revenue of $24.87 million for the quarter.
Mannatech Stock Up 4.8%
Mannatech stock traded up $0.41 during mid-day trading on Thursday, reaching $8.98. The company’s stock had a trading volume of 6,972 shares, compared to its average volume of 34,856. Mannatech has a 12 month low of $3.80 and a 12 month high of $9.97. The business’s 50 day simple moving average is $8.02 and its 200 day simple moving average is $6.35.
Analysts Set New Price Targets
A number of equities analysts have issued reports on MTEX shares. Wall Street Zen upgraded Mannatech to a “buy” rating in a report on Saturday, November 7th. Weiss Ratings upgraded Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, October 29th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Mannatech currently has a consensus rating of “Sell”.
View Our Latest Stock Report on Mannatech
Mannatech Company Profile
Mannatech, Incorporated develops and markets nutritional supplements, health and wellness products, and personal-care products through a direct-selling business model. Its product offerings have included dietary supplements, functional nutrition products, weight-management formulas, and skin-care products, with an emphasis on ingredients intended to support general wellness and healthy aging. The company is best known for its Ambrotose product line, which incorporates plant-sourced polysaccharides, as well as related nutritional supplements and wellness programs.
See Also
- Five stocks we like better than Mannatech
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
